This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
2 Citations 5 Q&As
Facts about Protein Wnt-5a.
In the presence of ROR2, inhibits the canonical Wnt pathway by promoting beta-catenin degradation via a GSK3-independent pathway that involves down-regulation of beta-catenin-induced reporter gene expression (By similarity). Suppression of the canonical pathway allows chondrogenesis to happen and inhibits tumor formation.
Human | |
---|---|
Gene Name: | WNT5A |
Uniprot: | P41221 |
Entrez: | 7474 |
Belongs to: |
---|
Wnt family |
hWNT5A; protein Wnt-5a; wingless-type MMTV integration site family, member 5A; WNT-5A protein; Wnt5a; Wnt-5a
Mass (kDA):
42.339 kDA
Human | |
---|---|
Location: | 3p14.3 |
Sequence: | 3; NC_000003.12 (55465715..55505261, complement) |
Expression is increased in differentiated thyroid carcinomas compared to normal thyroid tissue and anaplastic thyroid tumors where expression is low or undetectable. Expression is found in thyrocytes but not in stromal cells (at protein level) (PubMed:15735754). Detected in neonate heart and lung (PubMed:8288227).
Secreted, extracellular space, extracellular matrix. Secreted.
PMID: 8288227 by Clark C.C., et al. Molecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14-p21.
PMID: 14610063 by De Cat B., et al. Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements.
*More publications can be found for each product on its corresponding product page